netFormulary NHS
Birmingham, Sandwell, Solihull and environs APC Formulary
Maintained by Midlands and Lancashire Commissioning Support Unit
 Search
 Formulary Chapter 6: Endocrine system - Full Chapter
Notes:

This chapter is mostly updated. The section still outstanding is 6.4.1.1 (oestrogens and HRT). 
Chapter Links...
Link   Guideline for antidiabetics therapy for type 2 diabetes (March 2021)
Link   Guidelines for the use of blood glucose meters, test strips and lancets in diabetes (March 2020)
Link   BSSE APC Risk assessment- High strength insulins/ Biosimilars/ Fixed combination
Link   Gender dysphoria: Primary Care Responsibilities in Prescribing and Monitoring Hormone Therapy for Transgender and Non-Binary Adults (updated)
Link   Insulin Guidelines for Adults and Children with Type 1 and Type 2 Diabetes Mellitus V 1.0
Link   Insulin pen needles (June 2018)
Link   Primary Care Sick Day Guidance for the management of adult patients with diabetes mellitus
Link   Treatment and Management of Hypoglycaemia in Adults with Diabetes Mellitus
 Details...
06.01.06  Expand sub section  Diagnostic and monitoring agents for diabetes mellitus
 link Link    NICE NG17: Type 1 diabetes in adults: diagnosis and management (Aug 2015)
 link Link    NICE NG18: Diabetes (type 1 and type 2) in children and young adults (Aug 2015)
 link Link    NICE NG19: Diabetic foot problems: prevention and management
 link Link    NICE NG28:Type 2 diabetes in adults: management
 link Link    NICE NG3: Diabetes in pregnancy (Feb 2015)
06.01.06  Expand sub section  Blood glucose monitoring
Blood Glucose Meters
View adult BNF View SPC online View childrens BNF 		Formulary
Green 		 
Link  Guideline for the choice of blood glucose meters, test strips and lancets in diabetes
   
06.01.06  Expand sub section  Urinalysis
06.01.06  Expand sub section  Oral glucose tolerance test
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
 Display tracking information
click to search medicines.org.uk
 Link to adult BNF
click to search medicines.org.uk
 Link to children's BNF
click to search medicines.org.uk
 Link to SPCs
Cytotoxic Drug
 Cytotoxic Drug
CD
 Controlled Drug
High Cost Medicine
 High Cost Medicine
Cancer Drugs Fund
 Cancer Drugs Fund
NHSE
 NHS England
Homecare
 Homecare
CCG
 CCG

Traffic Light Status Information

Status Description

Prescribing in children

The APC notes that the informed use of unlicensed medicines or of licensed medicines for unlicensed applications (‘off-label’ use) is often necessary in paediatric practice.

The APC advises GPs to consider specialist prescribing recommendations for Green and Amber medicines that are not subject to ESCAs or RICaDs in combination with the information provided in the BNFC which goes beyond that of marketing authorisations. The BNFC has been designed for rapid reference and the information presented has been carefully selected to aid decisions on prescribing.
  

Green

 Medicines suitable for routine use within primary care. Initiation and maintenance of prescribing by Specialists, GPs and other qualified clinicians.   

Amber Initiation

 Amber Specialist Initiation: Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing when appropriate. This may be supported by a RICaD, annotated within the formulary entry.  

Amber Recommended

 Amber Specialist Recommendation: Initiation and maintenance of prescribing in Primary Care following recommendation from a Specialist.  

Amber SC

 Amber Shared Care: Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing, in accordance with an ESCA, annotated within the formulary entry.  

Red

 Medicines for initiation and maintenance prescribing by Specialists only.  

Black

 Non-formulary Medicines which APC/Trust DTC has actively reviewed and do not recommend for use.  

Grey

 Positive NICE TA and/or awaiting local clarification on place in therapy; Please contact your Medicines Optimisation team for more information.  

The term 'Specialist' refers to Consultants, General Practitioners and Independant Prescribers with a Specialist Interest.  

netFormulary